miR-31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma. - Test2 - elhamkhani - TriplyDB

miR-31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma.

miR-31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma.

http://www.wikidata.org/entity/Q37636790

about

Circulating miR-31 as an effective biomarker for detection and prognosis of human cancer: a meta-analysis.Klf4 inhibits tumor growth and metastasis by targeting microRNA-31 in human hepatocellular carcinoma MiR-31-5p-ACOX1 Axis Enhances Tumorigenic Fitness in Oral Squamous Cell Carcinoma Via the Promigratory Prostaglandin E2.Tissue and serum microRNA profile of oral squamous cell carcinoma patients.miR-31 and miR-145 as Potential Non-Invasive Regulatory Biomarkers in Patients with Endometriosis.A novel strategy to dissect endogenous gene transcriptional regulation in live cells.Loss of ARID1A Expression Correlates With Tumor Differentiation and Tumor Progression Stage in Pancreatic Ductal Adenocarcinoma.Cigarette smoke and chewing tobacco alter expression of different sets of miRNAs in oral keratinocytes.

P2860

Q33709838-7764EC86-5758-4E90-95A9-F309A7BEDBE6 Q37527769-D6B88DB6-156B-4694-A93A-5B08166F66F1 Q47133718-092A4D0C-B15A-4234-B79E-0FDDE188EB30 Q48251415-5D990DEC-7568-486E-8073-FCA9C8074151 Q50116323-7ED3580D-F71C-4109-BB22-A7A13BFBD1C4 Q50654331-33AC0A50-6377-420E-8D3C-A876A8889478 Q52372086-4E1E0C57-CC3D-4902-9EFA-143542A8CF08 Q55406484-F29809CE-694D-44E1-8150-9B3FBA7861C1

P2860

miR-31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma.

http://www.wikidata.org/entity/Q37636790

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

miR-31 targets ARID1A and enha ...... neck squamous cell carcinoma.

@en

miR-31 targets ARID1A and enha ...... neck squamous cell carcinoma.

@nl

type

label

miR-31 targets ARID1A and enha ...... neck squamous cell carcinoma.

@en

miR-31 targets ARID1A and enha ...... neck squamous cell carcinoma.

@nl

prefLabel

miR-31 targets ARID1A and enha ...... neck squamous cell carcinoma.

@en

miR-31 targets ARID1A and enha ...... neck squamous cell carcinoma.

@nl

P1433

Q37636790-68837EF2-E709-4126-A865-745376A1CCD5

P1476

Q37636790-9F672DC5-8EB0-4F67-AD6C-118DEC77DB38

P2093

Q37636790-3FF81731-89F0-4849-B5AB-D453C4540547

Q37636790-531C4A28-4D64-497C-AE94-F1F61F731BA1

Q37636790-61D2EC9A-1E13-4FD1-A07B-9BCFD19FBFD3

Q37636790-8BA0320C-2FCC-46A2-8AB4-4E347543356B

Q37636790-A423BA0C-3411-400D-B2CC-6EC194EE45CB

Q37636790-B027D5CB-AEE3-4139-B498-85067B491A95

Q37636790-BE342675-6322-4E24-91FF-D1CB7BD84A28

Q37636790-D520433B-F9F3-4396-B833-C2FF3D94B267

P2860

Q37636790-03CDA2E7-9109-4D3F-B531-31C9860E4F6D

Q37636790-05FEE081-6498-4421-B6DB-D0A2AC791FA2

Q37636790-08572047-5941-43E8-B248-F8579171A4D2

Q37636790-08A1D2A7-98A2-4CDE-A5DD-234FCF20AFF1

Q37636790-0BBB97A6-B04D-435C-9CD2-FAA80BB3EE1C

Q37636790-0E28416B-D9BB-4E8E-8CDD-5C224B7C0EF6

Q37636790-0EF9EC37-AE9C-4EDC-8B41-71DFB0ACAE4B

Q37636790-15C6964C-5BE1-4895-BF2E-ECDA66F1DA07

Q37636790-18301B4B-AB66-491D-99A3-C7B94296902A

Q37636790-20AF2791-9B52-440E-8975-3E1F40CA437B

P304

Q37636790-5570E600-63B9-41D5-BE8B-B43D721E4A6C

P31

Q37636790-C11A3BC6-A905-46C2-BC8D-EF27FA9A8E6B

P356

Q37636790-18368241-49F8-4A32-A04C-DBC6B30A18F3

P407

Q37636790-A3CD6319-84D1-41F5-9D4A-73819741CAC4

P433

Q37636790-9DA89605-6B87-41CA-8299-D0EA8918016B

P478

Q37636790-050CC63F-4717-4C47-A995-6277868A3268

P577

Q37636790-D2EE8326-B980-4E75-86AA-CB74906F7713

P698

Q37636790-5DFD5E91-1591-4436-9BD9-92B72F2373D5

P921

Q37636790-C0A0DF9D-77F9-438B-8DB2-DEA79580C509

P932

Q37636790-832E3AAC-F55C-4E79-B29F-3E487983724D

P356

ONCOTARGET.11138

P1433

P1476

miR-31 targets ARID1A and enha ...... neck squamous cell carcinoma.

@en

P2093

Cheng-Chieh Yang

http://www.w3.org/2001/XMLSchema#string

Chung-Ji Liu

http://www.w3.org/2001/XMLSchema#string

Hsi-Feng Tu

http://www.w3.org/2001/XMLSchema#string

Kuo-Wei Chang

http://www.w3.org/2001/XMLSchema#string

Shou-Yen Kao

http://www.w3.org/2001/XMLSchema#string

Shu-Chun Lin

http://www.w3.org/2001/XMLSchema#string

Wen-Cheng Lu

http://www.w3.org/2001/XMLSchema#string

Yu-Tung Chung

http://www.w3.org/2001/XMLSchema#string

P2860

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Comprehensive genomic characterization of head and neck squamous cell carcinomas

ARID1A mutations in cancer: another epigenetic tumor suppressor?

Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells

EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features

miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes.

An integrated workflow for analysis of ChIP-chip data.

MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells

Mammalian SWI/SNF--a subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B.

Roles of deletion of Arid1a, a tumor suppressor, in mouse ovarian tumorigenesis

P304

57254-57267

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.11138

http://www.w3.org/2001/XMLSchema#string

P407

P433

35

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27528032

http://www.w3.org/2001/XMLSchema#string

P921

head and neck squamous cell carcinoma

P932

5302987

http://www.w3.org/2001/XMLSchema#string